Institute Of Biomedical Stock Revenue
| MRES Stock | USD 0.01 0.0006 7.50% |
Institute of Biomedical fundamentals help investors to digest information that contributes to Institute's financial success or failures. It also enables traders to predict the movement of Institute Pink Sheet. The fundamental analysis module provides a way to measure Institute's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Institute pink sheet.
Institute |
Institute of Biomedical Company Revenue Analysis
Institute's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Institute Revenue | 1.41 M |
Most of Institute's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Institute of Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Institute of Biomedical reported 1.41 M of revenue. This is 99.98% lower than that of the Healthcare sector and 99.81% lower than that of the Biotechnology industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Institute Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Institute's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Institute could also be used in its relative valuation, which is a method of valuing Institute by comparing valuation metrics of similar companies.Institute is currently under evaluation in revenue category among its peers.
Institute Fundamentals
| Current Valuation | 198.84 K | |||
| Shares Outstanding | 66.28 M | |||
| Price To Book | 0.69 X | |||
| Revenue | 1.41 M | |||
| Net Income | 564.67 K | |||
| Cash Flow From Operations | 2.06 M | |||
| Beta | 1.71 | |||
| Market Capitalization | 639.61 K | |||
| Total Asset | 5.28 M | |||
| Retained Earnings | (55.58 M) | |||
| Current Asset | 2.56 M | |||
| Current Liabilities | 3.8 M | |||
| Z Score | -14.0 | |||
| Net Asset | 5.28 M |
About Institute Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Institute of Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Institute of Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Institute Pink Sheet Analysis
When running Institute's price analysis, check to measure Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Institute is operating at the current time. Most of Institute's value examination focuses on studying past and present price action to predict the probability of Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Institute's price. Additionally, you may evaluate how the addition of Institute to your portfolios can decrease your overall portfolio volatility.